# Actnova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/actnova

- Industry: Healthcare IT
- Headquarters: Daejeon-City, South Korea
- Website: www.actnova.io
- Total disclosed funding: $0.4M
- Latest round: Seed (Mar 1, 2023)
- Investors on record: 2

## About

Based in Seoul, South Korea, and founded in 2019 by its CEO Dae-Gon Kim, Actnova operates as an artificial intelligence-based clinical and non-clinical behavioral test analysis company. In August 2022, Actnova raised KRW 500million in seed funding from Kakao Ventures.

Actnova offers an artificial intelligent-based ??machine vision solution 'AVATAR 3D System' used to quantify clinical and non-clinical cognitive and behavioral symptoms and to identify correlations with various brain symptoms. The company uses its analytical ability to detect subtle symptom changes that could not be seen with the naked eye to determine the efficacy of a candidate substance in the drug development process. 

Actnova plans to use the seed funding in expanding its stride into the global market as well as launch 'Actverse', a subscription-type behavior analysis scoring service, to overseas markets.

## Funding rounds

- Seed, Mar 1, 2023 — Kakao Ventures, Korea Tech Incubator for Startup
- Seed, Aug 9, 2022, $0.4M — Kakao Ventures

## Investors

- Kakao Ventures (https://capitalatlas.ai/funds/kakao-ventures) — Seed
- Korea Tech Incubator for Startup — Seed